- In May 2021, Merck KGaA, a leading science and technology company, announced the extension of its ongoing collaboration with BioMed X, Heidelberg, Germany. As a result of this successful collaboration, multiple innovative discovery projects in new research areas have been started at Merck
- In April 2021, Agilent Technologies Inc. announced that it has acquired Resolution Bioscience, which is a leader in the development and commercialization of Next Generation Sequencing based precision oncology solutions
